Literature DB >> 8455667

Trends in Medicare payments in the last year of life.

J D Lubitz1, G F Riley.   

Abstract

BACKGROUND: Increased attention is being paid to the amount and types of medical services rendered in the period before death. There is a popular impression that a greater share of resources is being devoted to dying patients than in the past. We examined trends in the proportion of Medicare expenditures for persons 65 years old or older in their last year of life to determine whether there were any changes from 1976 to 1988.
METHODS: Using Medicare program data for 1976, 1980, 1985, and 1988, we classified Medicare payments according to whether they were made for people in their last year of life (decedents) or for survivors. We also assigned expenses for care in the last year of life according to intervals of 30 days before the person's death and examined trends according to age.
RESULTS: Reflecting the large overall increase in Medicare spending, Medicare costs for decedents rose from $3,488 per person-year in 1976 to $13,316 in 1988. However, Medicare payments for decedents as a percentage of the total Medicare budget changed little, fluctuating between 27.2 and 30.6 percent during the study period. Payments for care during the last 60 days of life expressed as a percentage of payments for the last year also held steady at about 52 percent. Furthermore, the pattern of lower payments for older as compared with younger decedents also prevailed throughout the study period.
CONCLUSIONS: The same forces that have acted to increase overall Medicare expenditures have affected care for both decedents and survivors. There is no evidence that persons in the last year of life account for a larger share of Medicare expenditures than in earlier years.

Entities:  

Mesh:

Year:  1993        PMID: 8455667     DOI: 10.1056/NEJM199304153281506

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  117 in total

1.  Evidence based palliative care. There is some evidence-and there needs to be more.

Authors:  I J Higginson
Journal:  BMJ       Date:  1999-08-21

2.  Financing end-of-life care in the USA.

Authors:  C Raphael; J Ahrens; N Fowler
Journal:  J R Soc Med       Date:  2001-09       Impact factor: 5.344

3.  Use of acute hospital beds does not increase as the population ages: results from a seven year cohort study in Germany.

Authors:  R Busse; C Krauth; F W Schwartz
Journal:  J Epidemiol Community Health       Date:  2002-04       Impact factor: 3.710

4.  Financing of care for fatal chronic disease: opportunities for Medicare reform.

Authors:  J Lynn; A Wilkinson; L Etheredge
Journal:  West J Med       Date:  2001-11

5.  "Serious and complex illness" in quality improvement and policy reform for end-of-life care.

Authors:  J Lynn; J H Forlini
Journal:  J Gen Intern Med       Date:  2001-05       Impact factor: 5.128

6.  Increasing longevity and Medicare expenditures.

Authors:  T Miller
Journal:  Demography       Date:  2001-05

7.  Comparing three life-limiting diseases: does diagnosis matter or is sick, sick?

Authors:  Karen E Steinhauser; Robert M Arnold; Maren K Olsen; Jennifer Lindquist; Judith Hays; Laura L Wood; Allison M Burton; James A Tulsky
Journal:  J Pain Symptom Manage       Date:  2011-01-28       Impact factor: 3.612

8.  Medical expenditures during the last year of life: findings from the 1992-1996 Medicare current beneficiary survey.

Authors:  Donald R Hoover; Stephen Crystal; Rizie Kumar; Usha Sambamoorthi; Joel C Cantor
Journal:  Health Serv Res       Date:  2002-12       Impact factor: 3.402

9.  Trends in inpatient treatment intensity among Medicare beneficiaries at the end of life.

Authors:  Amber E Barnato; Mark B McClellan; Christopher R Kagay; Alan M Garber
Journal:  Health Serv Res       Date:  2004-04       Impact factor: 3.402

Review 10.  [Age rationing : means of resource allocation in healthcare systems].

Authors:  C H R Wiese; C P Schepp; I Bergmann; J M Hinz; B M Graf; C L Lassen
Journal:  Anaesthesist       Date:  2012-04       Impact factor: 1.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.